Turn Therapeutics Inc. - Cash Flow | Stock Club

TTRXTurn Therapeutics Inc.$ --

Turn Therapeutics Inc.

Name: Turn Therapeutics Inc.（TTRX） Cash Flow Statement
Creator: Stock Club
License: https://stock-club.net/en/rule

TTRX

$ -

Review operating, investing, and financing cash flow trends alongside detailed breakdowns.

paymentsCash Flow (CF) Summary

Updated: 2026/06/30FY2026 Q2

Operating CF

-923,364USD

YoY -84.7%

Investing CF

-5,798USD

YoY +81.7%

Financing CF

0USD

YoY -100.0%

Cash Flow Trend (5 Years)

Cash in goes right, cash out goes left.

Investing CF

Operating CF

Financing CF

2023Free CF -1.4M

Operating

Investing

Financing

-1.4M

-44,306

+500,000

2024Free CF -1.5M

Operating

Investing

Financing

-1.4M

-99,475

+1.2M

2025Free CF -2.7M

Operating

Investing

Financing

-2.6M

-152,986

+6.9M

500,000

-44,306

-1.4M

2023

1.2M

-99,475

-1.4M

2024

6.9M

-152,986

-2.6M

2025

analyticsInvestment Efficiency Analysis

Operating CF vs Investing CF

Operating CF

Investing CF

-1.4M-44,306-1.4M-99,475-2.6M-152,9860

202320242025

waterfall_chartCash Flow Bridge (FY2025 Full Year)

Beginning / Ending

Increase

Decrease

10M5M0-5M

872,599

OpenBeginning Cash

-2.6M

Op.Operating CF

-152,986

Inv.Investing CF

6.9M

Fin.Financing CF

OtherOther

5.1M

CloseEnding Cash

Cash Flow Details

Unit: USD

Net Income from Continuing Operations

-3.19M

Depreciation and Amortization

52,746

Depreciation and Amortization

52,746

Stock-based Compensation

419,245

Other Non-cash Items

-2.21M

Adjustments to Net Income

-2.21M

Other Operating Activity

-2.21M

Change in Working Capital

2.37M

Change in Account Receivables

Change in Trade Receivables

Change in Inventory

Change in Payables and Accrued Expenses

2.26M

Other Working Capital Changes

105,025

Cash Flow from Operating Activities

-2.56M

Net Fixed Asset Activity

-152,986

Net Investment Securities Activity

Other Investing Activity

-152,986

Cash Flow from Investing Activities

-152,986

Net Borrowings

Net Issuance / Repurchase of Stock

6.92M

Issuance of Capital Stock

6.92M

Total Dividends Paid

Net Dividends Paid

Treasury / Other Financing Activity

Cash Flow from Financing Activities

6.92M

Beginning Cash and Cash Equivalents

872,599

Net Change in Cash and Cash Equivalents

4.20M

Net Change in Cash and Cash Equivalents

4.20M

Exchange Rate Changes

Ending Cash and Cash Equivalents

5.08M

Free Cash Flow

-2.72M

Item

2023

2024

2025

Net Income from Continuing Operations

Depreciation and Amortization

Stock-based Compensation

Other Non-cash Items

Adjustments to Net Income

Other Operating Activity

Change in Working Capital

Change in Account Receivables

Change in Trade Receivables

Change in Inventory

Change in Payables and Accrued Expenses

Other Working Capital Changes

Cash Flow from Operating Activities

-3.19M

52,746

419,245

-2.21M

2.37M

2.26M

105,025

-2.56M

Net Fixed Asset Activity

Net Investment Securities Activity

Other Investing Activity

Cash Flow from Investing Activities

-152,986

Net Borrowings

Net Issuance / Repurchase of Stock

Issuance of Capital Stock

Total Dividends Paid

Net Dividends Paid

Treasury / Other Financing Activity

Cash Flow from Financing Activities

6.92M

Beginning Cash and Cash Equivalents

Net Change in Cash and Cash Equivalents

Exchange Rate Changes

Ending Cash and Cash Equivalents

Free Cash Flow

872,599

4.20M

5.08M

-2.72M

Unlock Long-Term Cash Flow Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan